Kyle Peer

Kyle Peer

Temple University - Philadelphia / United States
Others
AD Scientific Index ID: 4850378
person_outline Kyle Peer's MOST POPULAR ARTICLES
1-) Janus kinase inhibition in the Aicardi–Goutières syndromeA Vanderver, L Adang, F Gavazzi, K McDonald, G Helman, DB Frank, ...New England Journal of Medicine 383 (10), 986-989, 20201312020
2-) Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sampleK Peer, L Rennert, KG Lynch, L Farrer, J Gelernter, HR KranzlerDrug and alcohol dependence 127 (1-3), 215-219, 20131312013
3-) DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample.L Rennert, C Denis, K Peer, KG Lynch, J Gelernter, HR KranzlerExperimental and clinical psychopharmacology 22 (1), 50, 2014702014
4-) Developmental outcomes of Aicardi Goutières syndromeL Adang, F Gavazzi, M De Simone, E Fazzi, J Galli, J Koh, ...Journal of child neurology 35 (1), 7-16, 2020552020
5-) Development of a neurologic severity scale for Aicardi Goutières syndromeLA Adang, F Gavazzi, AF Jawad, SV Cusack, K Kopin, K Peer, C Besnier, ...Molecular genetics and metabolism 130 (2), 153-160, 2020362020